Hurley Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
199
+67
+51% +$68.5K 0.12% 86
2026
Q1
$122K Buy
132
+1
+0.8% +$1.01K 0.07% 115
2025
Q4
$141K Buy
131
+3
+2% +$2.87K 0.08% 104
2025
Q3
$97.9K Buy
128
+14
+12% +$10.4K 0.06% 136
2025
Q2
$89K Buy
114
+11
+11% +$8.55K 0.06% 117
2025
Q1
$85.2K Sell
103
-100
-49% -$83.2K 0.06% 129
2024
Q4
$162K Buy
+203
New +$168K 0.13% 78

Other funds holding LLY

Hurley Capital's LLY Position: Q2 2026 in Review

Hurley Capital increased its Eli Lilly (LLY) stake by 51% in Q2 2026, buying an estimated $68.5K and bringing the position to 199 shares worth $238K. The position accounts for 0.12% of the portfolio, ranked #86.

Hurley Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hurley Capital held 199 shares of Eli Lilly worth $238K as of Q2 2026.
  • Hurley Capital bought 67 Eli Lilly shares in Q2 2026, an estimated $68.5K.
  • Eli Lilly made up 0.12% of Hurley Capital's portfolio in Q2 2026, its #86 holding.
  • Hurley Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.